Zeria Pharmaceutical Co., Ltd. Overview
Pro stress-test →Zeria Pharmaceutical, founded in 1955 and based in Tokyo, Japan, focuses on R&D, manufacturing and sales of prescription drugs as well as OTC products. The company holds a leading position in Japan's gastroenterology sector.
Strategic Profile
Pro stress-test →The company is mainly engaged in the development of ethical drug business, consumer healthcare business and other business. In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries, manufacturing and selling pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark.
Competitive Landscape
Pro stress-test →Zeria operates in Japan's competitive pharmaceutical market against major players like KYORIN Pharmaceutical and Mochida Pharmaceutical. The company differentiates through specialized focus on gastroenterology and a diversified consumer healthcare product portfolio. Its international footprint via Tillotts Pharma provides exposure beyond Japan's domestic market.
Industry Context
Zeria Pharmaceutical Co., Ltd. operates in Pharmaceuticals & Healthcare.
Key facts
Founded: 1955 · Headquarters: Tokyo, Japan · Employees: 1,746 · Revenue: $604.2M · Market cap: $686.1M